Lack of in vitro cultivation methods has inhibited the development of rapid, reliable diagnostic procedures for adenovirus-associated necrotizing bronchopneumonia in guinea pigs. Because polymerase chain reaction (PCR) techniques are well established for human adenoviruses, primers for the amplification of guinea pig adenovirus DNA were evaluated. The DNA for PCR was purified from the lung tissue of spontaneously infected and healthy guinea pigs. Adenovirus DNA could only be detected in the lungs of the infected animals. Subsequent sequence analysis of PCR products revealed that the guinea pig adenovirus is a distinct adenovirus.
Virus-associated necrotizing bronchopneumonia in guinea pigs is a spontaneous multifactorial disease that seems to have low morbidity, high mortality, and a worldwide distribution. After the first description in Germany 15 and experimental reproduction of the disease, 14 sporadic spontaneous cases were reported from the United States, 4, 6 Australia 7 and Switzerland. 10 A 10-year endemic "inhouse" occurrence of adenovirusassociated disease was reported in a British pharmaceutical research facility. 3 In all described spontaneous cases, some additional stress factors were involved. The etiologic agent is poorly characterized. Viral particles with typical ultrastructure and location for adenoviruses 6, 7, 11, 14 have been demonstrated by electron microscopy in pneumonic lesions. The guinea pig adenovirus (GPAdV) was only briefly discussed in a review of guinea pig viruses. 8 Rare occurrence of the disease and lack of in vitro cultivation methods 6, 14 have hampered further characterization of the GPAdV and the development of reliable diagnostic methods. A serologic surveillance method based on empirical crossreaction with the cultivable mouse adenovirus was developed and has been used for some years, 12, 13 but unfortunately this method is not specific for GPAdV.
All described adenoviruses share a common genome organization and architecture. The capsid consists of 252 capsomers arranged in icosahedral symmetry. Hexons form 240 of the 252 virion capsomeres and contain type-, subgenus-, and genus-specific determinants. 18, 21 The hexon genes showed three distinct segments, a variable middle segment, and 2 flanking, high-ly conserved regions. 16 Polymerase chain reaction (PCR) techniques are well established for detection of human adenoviruses in clinical samples, 17 and these techniques were used in an attempt to amplify GPAdV DNA derived from lung tissue with primers targeted to a conserved region of the hexon gene.
Materials and methods
Lung tissues. The lung tissues originated from 14 guinea pigs from 3 locations: Czech Republic, Germany, and USA (Table 1) . Nine guinea pigs showed spontaneous bronchopneumonia (experimental group), and 5 were healthy (control group). Bronchopneumonia was diagnosed from lung tissue showing characteristic gross pathologic changes (dark red consolidation areas) using standard histologic and electron microscopic procedures (Table 1) . Bacteriologic and parasitologic examinations were performed on 3 animals (NIH, Prague) (with negative results). Except for the 2 paraffinembedded lung samples, all lungs were delivered and stored deep frozen.
DNA purification from lung tissue. A commercial kit a was used for purification of total DNA. Twenty-five milligrams of lung tissue was lysed per sample. The DNA was eluted in 400 µl distilled water. The paraffin was removed from the 2 fixed tissue samples by extraction with xylene prior to lysis.
PCR. After comparison of the hexon gene sequences of the murine adenovirus type 1 (MAdV-1), 22 bovine adenovirus type 3 (BAdV-3), 9 human adenovirus type 2 (HAdV-2), 1 human adenovirus type 3 (HAdV-3), 18 and human adenovirus type 40 (HAdV-40), 20 several primer pairs were evaluated and tested with PCR. By applying the primer pair HX1 (forward primer): 5'-TTCATGCACATCGCCGG-3' and HX2 (reverse primer): 5'-CCGCGAATGTCAAAGTA-3', a PCR product could be generated.
The primer sequences were derived from the highly conserved 5' region of the hexon gene, and the primers were predicted to generate a 281-bp PCR product (corresponding to bp 34-314 of the MAdV-1 hexon gene sequence). Amplification was carried out in 100-µl reaction mixtures containing 40 µl of the 400-µl purified DNA, 50 mM KCl, 10 mM Tris HC1 (pH 8.3), 1.5 mM MgCl 2 , 200 µM of each dNTP, 0.5 µM of each primer, and 2.5 U Taq polymerase. Thermal cycling of the amplification mixture was performed in a programmable heat block for a total of 40 cycles. One cycle consisted of denaturation for 30 sec at 91 C, annealing for 30 sec at 45 C, and primer extension for 40 sec at 72 C; in the first cycle, the denaturation step continued for 400 sec at 91 C; in the last cycle, the extension step continued for 400 sec at 72 C. Five microliters of the final reaction product was analyzed in a regular 1% agarose gel, stained with ethidium bromide.
Construction of plasmids and DNA sequencing. Appropriate PCR products were concentrated, purified with microconcentrators, b and ligated into pUC 18. Four suitable clones per sample were selected, and subsequent sequencing of both DNA strands was performed using specific internal primers. Further analysis of sequence data was performed by computer. c The nucleotide sequence of the presented GPAdV hexon gene region has been deposited with the EMBL/Data library under accession number X95630.
Results
Lung tissue of 14 guinea pigs was tested for the presence of GPAdV by applying PCR. Nine lungs were from guinea pigs with bronchopneumonia. From these 9 lungs, DNA was purified from tissue areas showing typical pathologic changes ( Fig. 1) and containing adenovirus-like particles (Fig. 2) . DNA also was extracted from parts of these lungs showing no gross pathologic changes. As a control, DNA was purified from the lungs of 5 guinea pigs with no signs of bronchopneumonia. These lungs did not show any pathologic changes. PCR was performed by applying a primer pair targeted to the conserved 5' region of the adenovirus hexon gene. All tissue sample from the affected lung areas of the 9 guinea pigs with bronchopneumonia tested positive in PCR, whereas the tissue samples from the unaffected areas were negative. No PCR products could be detected in the samples from the healthy control animals. The generated amplimers were 281 bp long, corresponding to the previously predicted length. Sequencing of the 281 nucleotides and subsequent comparison with other adenovirus sequences revealed that GPAdV differs from all other previously characterized adeno-viruses. All sequenced clones were identical, and no other sequences, e.g., from MAdV-1, were found. Figure 3 shows the nucleotide and predicted amino acid sequence of the amplified GPAdV hexon region. The 281 nucleotides code for 93 amino acids. The predicted GPAdV amino acids were compared with the corresponding hexon regions of other adenovirus serotypes ( Fig. 4 ). MAdV-1, BAdV-3, HAdV-2, and HAdV-3 belong to the genus Mastadenovirus, and the fowl adenovirus type 10 (FAdV-10) belongs to the genus Aviadenovirus. 19 Among the human adenoviruses, HAdV-2 is clustered in subgenus C, HAdV-3 in subgenus B, and HAdV-40 in subgenus F. Although the sequences are located in a highly conserved region of the hexon, the homology values ranged between 61.7% and 77.5% on the DNA level and 51.6% and 83.9% on the protein level ( Table 2) . The low homology found for GPAdV and FAdV-10 was expected because FAdV-10 is an aviadenovirus and is very different from mastadenoviruses. 20 Because GPAdV is a distinct adenovirus, a specific PCR primer pair could be evaluated. Table 3 shows the PCR primer pair GPAdV1/GPAdV2, which is specific only for GPAdV. The corresponding nucleotide sequences of the adenoviruses with the highest level of homology are also shown. The number of nucleotide mismatches for GPAdV1 was 8 with MAdV, 6 with BAdV, and 7 with HAdV-40, and for GPAdV2 was 6 with MAdV, 5 with BAdV, and 4 with HAdV-40. All HX1/HX2 positive tissue sample were also tested with Table 2 . Percent similarity of the nucleotide and amino acid GPAdV hexon sequences with the corresponding hexon regions of other adenovirus serotypes.
the type-specific GPAdV1/GPAdV2 primers and produced positive PCR results. Although the HX1/HX2 primer pair is not specific for GPAdV and would also amplify, for example, MAdV-1 DNA (HX1: 1 mismatch with the MAdV-1 sequence; HX2: identical to the MAdV-1 sequence), it could nevertheless be used for routine PCR or with GPAdV1/GPAdV2 for nested PCR. No MAdV-1 DNA was amplified with the HX1/ HX2 primers, which clearly indicates that only GPAdV virions were present in the infected guinea pig lungs.
Discussion
Gross pathologic and histologic changes characteristic for GPAdV necrotizing bronchopneumonia were confirmed by electron microscopic examination, which revealed adenovirus-like particles in the lung tissue of 9 spontaneously infected guinea pigs. By sequencing PCR products generated from DNA directly prepared from the lung tissue, the presence of adenoviruses in the lung tissue was confirmed. Although the hexon gene was only partially sequenced, the amino acid sequence indicates that the structure of the corresponding hexon polypeptide is comparable to the structure found for other adenoviruses . 2 Furthermore, subsequent sequence analysis showed for the first time that GPAdV is a distinct adenovirus serotype. Previous data revealed that the sequences of adenoviruses belonging to the same subgenus are highly conserved in this region, e.g., the HAdV-2/HAdV-5 sequences (both belonging to subgenus C) are 100% identical. 5 Because even human adenoviruses belonging to different subgenera show higher levels of homology than do GPAdV and MAdV-1, which suggests that these two serotypes do not belong to the same subgenus. More precise phylogenetic studies can be made after successful cultivation of the virus or PCR amplification and subsequent sequencing of the complete GPAdV hexon gene.
Our data strongly suggest that GPAdV is the main etiologic factor for guinea pig bronchopneumonia; therefore, a rapid and reliable diagnostic procedure is needed. The current methods for the detection of GPAdV are laborious and time consuming and include necropsy and histologic findings (including electron microscopy) combined with negative bacteriology. A serologic test using the genus-specific hexon antigen or the MAdV strain FL antigen 12, 13 is also available. However, the reliability of this test is limited by false-positive results in the supposed case of healthy guinea pigs carrying MAdV. By applying this PCR technique, it will now be possible to rapidly and selectively detect GPAdV, which should result in significantly improved health monitoring and evaluation of guinea pigs used as experimental animals. Table 3 . Specific primers for the amplification of GPAdV DNA.
